Viewing StudyNCT06205498



Ignite Creation Date: 2024-05-06 @ 7:59 PM
Last Modification Date: 2025-12-17 @ 4:43 AM
Study NCT ID: NCT06205498
Status: None
Last Update Posted: 2025-08-22 00:00:00
First Post: 2023-07-06 00:00:00

Brief Title: Acalabrutinib Real World Italian obSErvational Study -ARISE
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Chronic Lymphocytic Leukemia
Keywords:
Name View
Observational View
Chronic Lymphocytic Leukemia View
acalabrutinib View
CLL View